Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06500143
What this trial is testing

Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery

Who this might be right for
Gastric Retention
Ciusss de L'Est de l'Île de Montréal 94
Large-scale testing (Phase 3)Study completedNCT04466618
What this trial is testing

Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes

Who this might be right for
HealthyType 2 Diabetes
Adrian Vella 23
Not applicableLooking for participantsNCT01851694
What this trial is testing

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Who this might be right for
Cystic FibrosisPancreatic Insufficiency
University of Pennsylvania 45
Not applicableStudy completedNCT03246451
What this trial is testing

The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D

Who this might be right for
Glucose Metabolism Disorders
University Hospital, Gentofte, Copenhagen 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06827002
What this trial is testing

Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults

Who this might be right for
Obesity and OverweightAppetite Regulation
University of Yaounde 1 248
Not applicableLooking for participantsNCT07506356
What this trial is testing

Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors

Who this might be right for
Diabete Type 2RegurgitationPulmonary Aspiration During Anaesthetic Induction
University Hospital, Geneva 38
Testing effectiveness (Phase 2)Looking for participantsNCT04731272
What this trial is testing

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Who this might be right for
Cystic FibrosisPancreatic InsufficiencyAbnormal Glucose Tolerance+1 more
University of Pennsylvania 30
Not applicableLooking for participantsNCT07224880
What this trial is testing

Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
glp1 AgonistGene ExpressionSkin Laxity
Cytrellis Biosystems, Inc. 10
Not applicableActive Not RecruitingNCT05333003
What this trial is testing

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity

Who this might be right for
Schizophrenia Spectrum Disorders
Centre for Addiction and Mental Health 92
Early research (Phase 1)Not Yet RecruitingNCT07550634
What this trial is testing

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

Who this might be right for
Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B)Hepatic Insufficiency (MeSH ID: D048550)
MindRank AI Ltd 32
Large-scale testing (Phase 3)UnknownNCT01254123
What this trial is testing

Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)

Who this might be right for
Patients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI).
Amsterdam UMC, location VUmc 40
Not applicableStudy completedNCT03520062
What this trial is testing

The Effect of Liraglutide on Pancreatic Hormones and Its Size

Who this might be right for
Obesity
Nicolai Jacob Wewer Albrechtsen 14
Not applicableActive Not RecruitingNCT07685834
What this trial is testing

Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss

Who this might be right for
Lax Skin
Sofwave Medical LTD 30
Testing effectiveness (Phase 2)UnknownNCT02611232
What this trial is testing

Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults

Who this might be right for
Type 1 Diabetes
University of Oulu 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07430332
What this trial is testing

GLP-1 RA for Stage 1 Type 1 Diabetes

Who this might be right for
Stage 1 Diabetes Mellitus, Type 1
Children's Hospital Medical Center, Cincinnati 15
Large-scale testing (Phase 3)Study completedNCT07834398
What this trial is testing

Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes

Who this might be right for
Non-diabetec ObesityObesity (Disorder)
Zagazig University 150
Not applicableLooking for participantsNCT07316816
What this trial is testing

Stanford Pediatric Healthy Weight Index

Who this might be right for
Obesity & Overweight
Stanford University 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT06287307
What this trial is testing

Semaglutide 2.4mg for Low Responders After Bariatric Surgery

Who this might be right for
ObesityObesity, MorbidWeight Gain
Zuyderland Medisch Centrum 152
Not applicableStudy completedNCT05136287
What this trial is testing

SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.

Who this might be right for
Weight LossDiabetes Mellitus, Type 2Quality of Life+1 more
Jose Seijas Amigo 140
Not applicableNot Yet RecruitingNCT07535892
What this trial is testing

Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation

Who this might be right for
Weight LossGLP - 1Weight Loss Maintenance+1 more
University of Alabama at Birmingham 64
Next Page